Table 5.
Models | Covariates | UACR(n=207) | |||
---|---|---|---|---|---|
Normoalbuminuria (n=107) | Albuminuria (n=100) | ||||
OR (95% CI) | P | OR (95% CI) | P | ||
Unadjusted | Asprosin | 1 | – | 1.954(1.357~2.812) | <0.001 |
DM duration | 1 | – | 1.006(1.002~1.01) | 0.001 | |
SBP | 1 | – | 1.051(1.027~1.076) | <0.001 | |
HAB1c | 1 | – | 1.074(0.908~1.272) | 0.404 | |
TG | 1 | – | 1.142(0.899~1.452) | 0.277 | |
TC | 1 | – | 0.979(0.706~1.357) | 0.898 | |
Model 1 | Asprosin | 1 | – | 1.953(1.357~2.812) | <0.001 |
DM duration | 1 | – | 1.006(1.002~1.01) | 0.002 | |
SBP | 1 | – | 1.05(1.025~1.076) | <0.001 | |
HAB1c | 1 | – | 1.079(0.91~1.279) | 0.381 | |
TG | 1 | – | 1.151(0.901~1.47) | 0.259 | |
TC | 1 | – | 0.988(0.707~1.38) | 0.943 | |
Model 2 | Asprosin | 1 | – | 2.019(1.382~2.952) | <0.001 |
DM duration | 1 | – | 1.007(1.003~1.01) | 0.001 | |
SBP | 1 | – | 1.056(1.03~1.082) | <0.001 | |
HAB1c | 1 | – | 1.059(0.884~1.269) | 0.533 | |
TG | 1 | – | 1.229(0.955~1.581) | 0.109 | |
TC | 1 | – | 0.903(0.644~1.267) | 0.556 | |
Model 3 | Asprosin | 1 | – | 1.931(1.341~2.781) | <0.001 |
DM duration | 1 | – | 1.006(1.003~1.01) | 0.001 | |
SBP | 1 | – | 1.05(1.026~1.075) | <0.001 | |
HAB1c | 1 | – | 1.093(0.918~1.303) | 0.317 | |
TG | 1 | – | 1.096(0.86~1.397) | 0.460 | |
TC | 1 | – | 0.968(0.69~1.358) | 0.853 | |
Model 4 | Asprosin | 1 | – | 2.003(1.37~2.928) | <0.001 |
DM duration | 1 | – | 1.007(1.003~1.011) | 0.001 | |
SBP | 1 | – | 1.055(1.029~1.082) | <0.001 | |
HAB1c | 1 | – | 1.074(0.892~1.294) | 0.450 | |
TG | 1 | – | 1.177(0.904~1.53) | 0.226 | |
TC | 1 | – | 0.905(0.635~1.291) | 0.582 |
Notes: Model 1 adjusted for age and sex, Model 2 adjusted for smoking and drug use, Model 3 adjusted for BMI and HOMA-IR, Model 4 adjusted for age, sex, smoking, drug use, BMI, and HOMA-IR. P < 0.05 was considered to be statistically significant.